Protein Chip Market Analysis

Global Protein Chip Market Overview

Protein Chip Market Size was valued at USD 1.1 Billion in 2022. The protein chip market industry is projected to grow from USD 1.17 Billion in 2023 to USD 1.973 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.71% during the forecast period (2023 - 2032). The emergence of effective and sophisticated diagnosis technologies as well as the rising prevalence and incidence rate of cancer patients around the world are the key market drivers propelling the market for protein chips.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Protein Chip Market Trends

• Growing  incidence and prevalence of cancer is driving the market growth

The lifestyle of the people in the modern world has undergone a tremendous change. Alcohol usage, smoking, and drug abuse are becoming more and more common. The modern world also promotes a sedentary lifestyle, which has resulted in a lack of physical activity. Obesity, which is the root cause of many chronic lifestyle diseases, is a result of physical inactivity. The condition has gotten worse due to a lack of activity and a diet high in processed, sugary, and nutrient-poor foods from expanding fast-food retail outlets. Diabetes in the general population is also a result of this diet. 

The incidence of cancer is increasing due to environmental factors like air pollution. Every cancer is unique, requiring a tailored or focused strategy to management or therapy. Early cancer diagnosis is the first step in lowering the burden of the disease or stopping its growth in its early stages. The expanding use of protein chips in cancer research and diagnostics can be attributed to rising disease awareness and a strong diagnostic infrastructure. Finding biomarkers in cancer cells is a highly successful and economical process using a protein chip. The identification of biomarkers or protein arrays enables the oncologist to create a successful, patient-specific treatment strategy. As a result, the expansion of the worldwide protein chip market CAGR will be fueled by the rising incidence and prevalence of cancer.

Protein is present in all organisms. The primary cornerstone of any medical study is an understanding of protein organisation, structure, and interactions with other elements and the environment. The scientific community can solve problems relating to the human body or the living world by having a better grasp of proteins. It teaches students to comprehend the biological processes, illnesses, infections, diseases, disorders, and viruses that occur within the human body more thoroughly. With a greater grasp of the issue, many illnesses and problems can be avoided or addressed. 

The development of protein chip technology has the potential to advance medical research in the areas of illness monitoring, drug discovery, prognosis, and other pertinent areas. The usefulness of protein chips in illness diagnosis, disease monitoring, vaccine research, and therapeutic development during the COVID-19 pandemic is a prime illustration of this technology's promise in medicine. Growing demand for protein chips has prompted both public and private market participants to invest more in research and development, creating attractive potential for the market's growth throughout the forecast period. Thus, driving the protein chip market revenue.

Protein Chip Market Segment Insights

Protein Chip Type Insights

The protein chip market segmentation, based on type includes Analytical Microarrays, Functional Protein Microarrays and Reverse Phase Protein Microarrays. The analytical microarrays segment dominated the market. A complicated mixture of proteins is profiled using analytical protein microarrays to identify their binding affinities. With the aid of analytical microarrays, the specifics and amounts of protein expression are also examined. Research on antibodies, aptamers, or affibodies is done using analytical protein microarrays. But the main and most important application of it is to research antibodies, which are crucial for tracking illness progression and developing new medications.

Figure 1  Protein Chip Market, by Type, 2022 & 2032 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Protein Chip Application Insights

The protein chip market segmentation, based on application, includes Protein Identification, Clinical Diagnostics, Proteomics and Others. The proteomics category generated the most income. Due to the usage of proteomics in conduction chip-based drug discovery investigations and biomedical research, the market is anticipated to continue expanding steadily. The market for protein chips as a whole has a market share of 50%. Spectroscopy, X-ray crystallography, and chromatography are a few of the many applications it can be used for.

Protein Chip End User Insights

The protein chip market segmentation, based on end user includes Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes and Pharmaceutical & Biotechnology Companies. The academic & research institutes segment dominated the market. DNA microarrays are being gradually replaced in several fields by protein chips, a novel technology. Protein chips have been used to get around the DNA microarray's limitations in terms of protein expression and profiling. Over the past ten years, the potential of protein chips in cancer, diagnosis, drug monitoring, drug development, targeted therapy or treatment, and personalized medicine has received significant attention.

Protein Chip Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American protein chip market area will dominate this market as a result of the increased cancer incidence. Given the sedentary lifestyle, excessive intake of processed sugary foods, and lack of physical activity, the prevalence is rising, which can be ascribed to the rising obese population. The increased cancer incidence in the area is due to both excessive alcohol use and smoking. The expansion of the regional market is further aided by the presence of significant industrial players and top academic and research institutions.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2  PROTEIN CHIP MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe protein chip market accounts for the second-largest market share. The growth of the market has been fueled by the development of high-quality healthcare and an increase in cancer incidence as a result of population growth. As a result of this method's numerous applications, governments are becoming more interested in it. Therefore, government actions will increase the trust of research centers in the area. Further, the German protein chip market held the largest market share, and the UK protein chip market was the fastest growing market in the European region

The Asia-Pacific Protein chip Market is expected to grow at the fastest CAGR from 2023 to 2032 due to the region's growing need for technical innovation combined with the increased occurrence of infections, diseases, and cancer cases. Additionally, the population increase in nations like China and India is the main driver of the growth. The region's increasing sickness cases that require diagnosis are another factor driving the market's growth. Moreover, China’s protein chip market held the largest market share, and the Indian protein chip market was the fastest growing market in the Asia-Pacific region.

Protein Chip Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the protein chip market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, protein chip industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  protein chip industry to benefit clients and increase the market sector. In recent years, the protein chip industry has offered some of the most significant advantages to market. Major players in the protein chip market attempting to increase market demand by investing in research and development operations include Sengenics (US), Thermo Fisher Scientific Inc (US), Microarrays Inc (US), Agilent Technologies Inc (US), Bio-Rad Laboratories Inc (US), Full Moon BioSystems Inc (US), CDI Laboratories Inc (US), OriGene Technologies Inc (US) and Innopsys (France).

In order to build the largest commercial collection of full-length human cDNAs in a common expression vector, OriGene Technologies was established as a provider of research tools. System biology techniques have made it possible to identify pertinent therapeutic targets thanks to the availability of the whole human genome sequence and the subsequent development of genome-based technologies. The goal of OriGene is to develop comprehensive, genome-wide research tools and technological platforms that will allow researchers to examine entire biological pathways and, in turn, gain a better knowledge of how diseases, such as cancer, work.

Private firm Innopsys specialises in the creation and marketing of software and scanners for fluorescence confocal microscopy. InnoScan, a full-range microarray scanner, and Mapix, an image analysis programme, are now being marketed by the business. The InnoScan System product line combines sensitivity, speed, and resolution (up to 0.5 m/pixel) and is compatible with all types of microarrays.

Key Companies in the protein chip market include

• Sengenics (US)


• Thermo Fisher Scientific Inc (US)


• Microarrays Inc (US)


• Agilent Technologies Inc (US)


• Bio-Rad Laboratories Inc (US)


• Full Moon BioSystems Inc (US)


• CDI Laboratories Inc (US)


• OriGene Technologies Inc (US)


• Innopsys (France)

Protein Chip Industry Developments

February 2023 Clinical diagnostics, the creation of vaccines, and the search for new medicines are only a few of the many applications supported by the core technique of recombinant protein production. High-throughput synthesis of correctly folded, functional, and complete proteins, however, is associated with a high failure rate. Protein misfolding might result in false positive results. For this reason, Sengenics KREXTM technology makes use of Biotin Carboxyl Carrier Protein (BCCP) as a solubility enhancer and folding marker.

March 2022 The i-Ome Protein Array Kit has been made available for purchase, according to Sengenics. The high-density, slide-based i-Ome Protein Array Kit includes 1600+ immobilized, full-length, fully folded human proteins. A best-in-class autoantibody discovery tool is now available to researchers working on autoantibody biomarker identification in the fields of autoimmune disease, immuno-oncology, and neuroinflammation thanks to the new product that makes the KREXTM technology more widely available.

January 2022 In order to provide the SomaScan Proteomics Assay to Illumina's current and upcoming high-throughput next-generation sequencing (NGS) platforms, the companies inked a final co-development agreement. The high-throughput portion of the proteomics market, which is rapidly expanding, will benefit from this collaboration.

Protein Chip Market Segmentation

Protein Chip Type Outlook (USD Billion, 2018-2032)

• Analytical Microarrays


• Functional Protein Microarrays


• Reverse Phase Protein Microarrays

Protein Chip Application Outlook (USD Billion, 2018-2032)

• Protein Identification


• Clinical Diagnostics


• Proteomics


• Others

Protein Chip End User Outlook (USD Billion, 2018-2032)

• Hospitals & Clinics


• Diagnostic Laboratories 


• Academic & Research Institutes


• Pharmaceutical & Biotechnology Companies


• Others

Protein Chip Regional Outlook (USD Billion, 2018-2032)

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America